2,6-Difluorobenzoyl isocyanate

We are 2,6-Difluorobenzoyl isocyanate CAS:60731-73-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2,6-Difluorobenzoyl isocyanate
CAS.NO:60731-73-9
Synonyms:2,6-Difluorobenzoyl isocyanate
2,6-difluoro-benzoylisocyanate
2,5-DIFLUORO-7,7,8,8-TETRACYANOQUINODIMETHANE
 
Physical and Chemical Properties:
Density 1.32 g/cm3
Boiling Point 66ºC (0.2 mmHg)
Melting Point 140-143.3ºC
Molecular Formula C8H3F2NO2
Molecular Weight 183.11200
Index of Refraction 1.511
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Hexaflumuron(CAS:86479-06-3)、Diflubenzuron(CAS:35367-38-5)、Chlorfluazuron(CAS:71422-67-8)、Flufenoxuron(CAS:101463-69-8)、Fluazuron(CAS:86811-58-7)、Novaluron(CAS:116714-46-6)、Lufenuron(CAS:103055-07-8) and Teflubenzuron(CAS:83121-18-0).

2,6-Difluorobenzoyl isocyanate


Related News: FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus.9- (2-BroMo-fenil) -9-fenil-9H-fluoreno CAS:1998216-26-4 FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus.Ethyl 2-oxo-4-phenylbutyrate CAS:64920-29-2 With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand.(3-metil-4- (2,2,2-trifluoroetoxi) piridin-2-il) metanol CAS:103577-66-8 With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand.With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved.

Related Products
Product Name
2,2′-Dibromodiethyl ether View Details
2,5-Dibromo-3-methylpyridine View Details
3-Bromo-6-hydroxy-2-methylpyridine View Details
(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyric acid manufacturer 4-Butylphenylboronic acid manufacturer 2-Fluoro-6-nitro-n-phenylbenzamide manufacturer 6-Bromo-2-chloro-3-iodopyridine manufacturer 2,4,6-Trimethylbenzoic acid manufacturer